Literature DB >> 26969842

RASA1 somatic mutation and variable expressivity in capillary malformation/arteriovenous malformation (CM/AVM) syndrome.

Colleen F Macmurdo1, Whitney Wooderchak-Donahue2,3, Pinar Bayrak-Toydemir2,3, Jenny Le2, Matthew B Wallenstein1, Carlos Milla1, Joyce M C Teng4, Jonathan A Bernstein1, David A Stevenson1.   

Abstract

Germline mutations in RASA1 are associated with capillary malformation-arteriovenous malformation (CM-AVM) syndrome. CM-AVM syndrome is characterized by multi-focal capillary malformations and arteriovenous malformations. Lymphatic anomalies have been proposed as part of the phenotype. Intrafamilial variability has been reported, suggesting modifiers and somatic events. The objective of the study was to identify somatic RASA1 "second hits" from vascular malformations associated with CM-AVM syndrome, and describe phenotypic variability. Participants were examined and phenotyped. Genomic DNA was extracted from peripheral blood on all participants. Whole-exome sequencing was performed on the proband. Using Sanger sequencing, RASA1 exon 8 was PCR-amplified to track the c.1248T>G, p.Tyr416X germline variant through the family. A skin biopsy of a capillary malformation from the proband's mother was also obtained, and next-generation sequencing was performed on DNA from the affected tissue. A familial germline heterozygous novel pathogenic RASA1 variant, c.1248T>G (p.Tyr416X), was identified in the proband and her mother. The proband had capillary malformations, chylothorax, lymphedema, and overgrowth, while her affected mother had only isolated capillary malformations. Sequence analysis of DNA extracted from a skin biopsy of a capillary malformation of the affected mother showed a second RASA1 somatic mutation (c.2245C>T, p.Arg749X). These results and the extreme variable expressivity support the hypothesis that somatic "second hits" are required for the development of vascular anomalies associated with CM-AVM syndrome. In addition, the phenotypes of the affected individuals further clarify that lymphatic manifestations are also part of the phenotypic spectrum of RASA1-related disorders.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  RASA1; arteriovenous malformation; capillary malformation; somatic mutation

Mesh:

Substances:

Year:  2016        PMID: 26969842     DOI: 10.1002/ajmg.a.37613

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  23 in total

Review 1.  Angioarchitecture of Hereditary Arteriovenous Malformations.

Authors:  Patricia E Burrows
Journal:  Semin Intervent Radiol       Date:  2017-09-11       Impact factor: 1.513

Review 2.  The pathobiology of vascular malformations: insights from human and model organism genetics.

Authors:  Sarah E Wetzel-Strong; Matthew R Detter; Douglas A Marchuk
Journal:  J Pathol       Date:  2016-12-04       Impact factor: 7.996

3.  RASA1-dependent cellular export of collagen IV controls blood and lymphatic vascular development.

Authors:  Di Chen; Joyce M Teng; Paula E North; Philip E Lapinski; Philip D King
Journal:  J Clin Invest       Date:  2019-06-11       Impact factor: 14.808

4.  RASA1 regulates the function of lymphatic vessel valves in mice.

Authors:  Philip E Lapinski; Beth A Lubeck; Di Chen; Abbas Doosti; Scott D Zawieja; Michael J Davis; Philip D King
Journal:  J Clin Invest       Date:  2017-05-22       Impact factor: 14.808

5.  Somatic Mutations in Vascular Malformations of Hereditary Hemorrhagic Telangiectasia Result in Bi-allelic Loss of ENG or ACVRL1.

Authors:  Daniel A Snellings; Carol J Gallione; Dewi S Clark; Nicholas T Vozoris; Marie E Faughnan; Douglas A Marchuk
Journal:  Am J Hum Genet       Date:  2019-10-17       Impact factor: 11.025

6.  Expanding the clinical and molecular findings in RASA1 capillary malformation-arteriovenous malformation.

Authors:  Whitney L Wooderchak-Donahue; Peter Johnson; Jamie McDonald; Francine Blei; Alejandro Berenstein; Michelle Sorscher; Jennifer Mayer; Angela E Scheuerle; Tracey Lewis; J Fredrik Grimmer; Gresham T Richter; Marcie A Steeves; Angela E Lin; David A Stevenson; Pinar Bayrak-Toydemir
Journal:  Eur J Hum Genet       Date:  2018-06-11       Impact factor: 4.246

7.  Somatic second hit mutation of RASA1 in vascular endothelial cells in capillary malformation-arteriovenous malformation.

Authors:  Philip E Lapinski; Abbas Doosti; Valerie Salato; Paula North; Patricia E Burrows; Philip D King
Journal:  Eur J Med Genet       Date:  2017-10-09       Impact factor: 2.708

Review 8.  EphrinB2-EphB4-RASA1 Signaling in Human Cerebrovascular Development and Disease.

Authors:  Xue Zeng; Ava Hunt; Sheng Chih Jin; Daniel Duran; Jonathan Gaillard; Kristopher T Kahle
Journal:  Trends Mol Med       Date:  2019-02-25       Impact factor: 11.951

Review 9.  A review of craniofacial and dental findings of the RASopathies.

Authors:  H Cao; N Alrejaye; O D Klein; A F Goodwin; S Oberoi
Journal:  Orthod Craniofac Res       Date:  2017-06       Impact factor: 1.826

10.  Integrated in silico MS-based phosphoproteomics and network enrichment analysis of RASopathy proteins.

Authors:  Javier-Fernando Montero-Bullón; Óscar González-Velasco; María Isidoro-García; Jesus Lacal
Journal:  Orphanet J Rare Dis       Date:  2021-07-06       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.